Evidence map›Paper›PMID 35067821›Full record

ArticleJournal of the Egyptian National Cancer Institute2022

The outcome of postoperative radiation therapy following plastic surgical resection of recurrent ear keloid: a single institution experience.

Reham Mohamed, Abosaleh Abosaleh Elawadi, Reham Al-Gendi, Safa Al-Mohsen, Shabeer Wani, Ahmed Wafa

Open access · diamondAbstract read
In one paragraph

Article in Journal of the Egyptian National Cancer Institute, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. New standoff-factor formula for orthovoltage radiotherapy treatments.Physical and engineering sciences in medicine · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Reham MohamedRadiation Oncology Department, National Cancer Institute, Cairo University, Cairo, Egypt. dr.reham71@hotmail.com.ORCID http://orcid.org/0000-0001-8495-1185
Abosaleh Abosaleh ElawadiMedical Physics Section, Radiation Oncology Department, Comprehensive Cancer Center, KFMC, Riyadh, Saudi Arabia.
Reham Al-GendiMedical Physics Section, Radiation Oncology Department, Comprehensive Cancer Center, KFMC, Riyadh, Saudi Arabia.
Safa Al-MohsenMedical Physics Section, Radiation Oncology Department, Comprehensive Cancer Center, KFMC, Riyadh, Saudi Arabia.
Shabeer WaniPlastic Surgery Department, King Fahad Medical City, Riyadh, Saudi Arabia.
Ahmed WafaPlastic Surgery Department, King Fahad Medical City, Riyadh, Saudi Arabia.
King Fahd Medical City · SACairo University · EGMansoura University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEar keloids are abnormal continuously growing healing process following cutaneous injury. Surgical excision is the standard treatment strategy; however, 50-80% of cases develop recurrence. Adjuvant radiotherapy (RT) is commonly offered with a marked decrease in the recurrence rate. The variation in RT protocols used in different studies leads to a bias of results analysis. The aim is to present our experience of using surgical excision with postoperative radiotherapy for recurrent ear keloids. Also, studying different variables especially dose and keloid size that affects recurrence rate. Radiotherapy complications were reported and assessed. PATIENTS AND

methodsKeloids between 2006 and 2021 were retrospectively reviewed. Fifty-five ear keloids out of 83 cases who received RT after surgical excision were included in the study. Different dose regimens including 13 Gy/1fx, 8 Gy/1fx, 10 Gy/2fx, 15 Gy/3fx, and other fractionated regimens were used. The Median follow-up period was 35 months. Recurrence-free rate (RFR), side effects, and prognostic factors were assessed.

resultsThe overall 2-year RFR was 88 ± 5%. The 2-year RFR was 83 ± 8% for dose regimens with biological effective dose (BED) ≤ 40 and 92 ± 5% for regimens with BED > 40 Gy with an insignificant p value. The 2-year RFR was 74 ± 10% compared to 97 ± 3% for keloids > 2 cm and keloids ≤ 2 cm respectively (p value 0.02). The higher dose used for keloids with > 2 cm size significantly improved RFR. The orthovoltage therapy showed marginally better 2-year RFR compared to electron beam therapy; however, statistically insignificant (p value 0.09). The side effects were minimal with no reported second malignancy or serious G3-4 complications.

conclusionExcision followed by RT is a safe and effective treatment for recurrent ear keloids. Low and modest radiation doses are effective; however, a higher dose is recommended for keloids > 2 cm. We recommend a prospective larger-scale study to test the effect of dose and keloid size on the treatment results.

Indexed as

KeloidHumansPlasticsProspective StudiesRadiotherapy, AdjuvantRecurrenceRetrospective StudiesTreatment OutcomePlasticsKeloidOrthovoltagePostoperativeRadiotherapy

Identifiers

PMID35067821
PMCPMC13314226
OpenAlexW4206919370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.